CLVLF
Price
$6.81
Change
-$1.17 (-14.66%)
Updated
Sep 25 closing price
Capitalization
373.02M
QNRX
Price
$7.28
Change
-$0.13 (-1.75%)
Updated
Sep 26 closing price
Capitalization
4.28M
Interact to see
Advertisement

CLVLF vs QNRX

Header iconCLVLF vs QNRX Comparison
Open Charts CLVLF vs QNRXBanner chart's image
Clinuvel Pharmaceuticals
Price$6.81
Change-$1.17 (-14.66%)
Volume$405
Capitalization373.02M
Quoin Pharmaceuticals
Price$7.28
Change-$0.13 (-1.75%)
Volume$23.05K
Capitalization4.28M
CLVLF vs QNRX Comparison Chart in %
Loading...
CLVLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLVLF vs. QNRX commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLVLF is a Hold and QNRX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (CLVLF: $6.81 vs. QNRX: $7.28)
Brand notoriety: CLVLF and QNRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLVLF: 61% vs. QNRX: 20%
Market capitalization -- CLVLF: $369.72M vs. QNRX: $4.28M
CLVLF [@Biotechnology] is valued at $369.72M. QNRX’s [@Biotechnology] market capitalization is $4.28M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLVLF’s FA Score shows that 1 FA rating(s) are green whileQNRX’s FA Score has 1 green FA rating(s).

  • CLVLF’s FA Score: 1 green, 4 red.
  • QNRX’s FA Score: 1 green, 4 red.
According to our system of comparison, QNRX is a better buy in the long-term than CLVLF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLVLF’s TA Score shows that 4 TA indicator(s) are bullish while QNRX’s TA Score has 4 bullish TA indicator(s).

  • CLVLF’s TA Score: 4 bullish, 5 bearish.
  • QNRX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CLVLF is a better buy in the short-term than QNRX.

Price Growth

CLVLF (@Biotechnology) experienced а -14.66% price change this week, while QNRX (@Biotechnology) price change was -5.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.14%. For the same industry, the average monthly price growth was +9.25%, and the average quarterly price growth was +54.64%.

Industries' Descriptions

@Biotechnology (+4.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLVLF($373M) has a higher market cap than QNRX($4.28M). CLVLF has higher P/E ratio than QNRX: CLVLF (16.42) vs QNRX (0.01). CLVLF YTD gains are higher at: -19.408 vs. QNRX (-68.028). CLVLF has higher annual earnings (EBITDA): 57.2M vs. QNRX (-12.58M). CLVLF has more cash in the bank: 224M vs. QNRX (7.79M). CLVLF has less debt than QNRX: CLVLF (529K) vs QNRX (6.21M). CLVLF has higher revenues than QNRX: CLVLF (95M) vs QNRX (0).
CLVLFQNRXCLVLF / QNRX
Capitalization373M4.28M8,709%
EBITDA57.2M-12.58M-455%
Gain YTD-19.408-68.02829%
P/E Ratio16.420.01216,181%
Revenue95M0-
Total Cash224M7.79M2,875%
Total Debt529K6.21M9%
FUNDAMENTALS RATINGS
CLVLF vs QNRX: Fundamental Ratings
CLVLF
QNRX
OUTLOOK RATING
1..100
3031
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
20
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
51100
PRICE GROWTH RATING
1..100
5589
P/E GROWTH RATING
1..100
7942
SEASONALITY SCORE
1..100
5035

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CLVLF's Valuation (3) in the null industry is in the same range as QNRX (20) in the Biotechnology industry. This means that CLVLF’s stock grew similarly to QNRX’s over the last 12 months.

CLVLF's Profit vs Risk Rating (100) in the null industry is in the same range as QNRX (100) in the Biotechnology industry. This means that CLVLF’s stock grew similarly to QNRX’s over the last 12 months.

CLVLF's SMR Rating (51) in the null industry is somewhat better than the same rating for QNRX (100) in the Biotechnology industry. This means that CLVLF’s stock grew somewhat faster than QNRX’s over the last 12 months.

CLVLF's Price Growth Rating (55) in the null industry is somewhat better than the same rating for QNRX (89) in the Biotechnology industry. This means that CLVLF’s stock grew somewhat faster than QNRX’s over the last 12 months.

QNRX's P/E Growth Rating (42) in the Biotechnology industry is somewhat better than the same rating for CLVLF (79) in the null industry. This means that QNRX’s stock grew somewhat faster than CLVLF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLVLFQNRX
RSI
ODDS (%)
Bullish Trend 2 days ago
41%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
57%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
57%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
49%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
56%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
51%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
N/A
Bullish Trend 10 days ago
87%
Declines
ODDS (%)
N/A
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
61%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
43%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
CLVLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VSCO26.240.65
+2.54%
Victoria's Secret & Co
SCI82.111.28
+1.58%
Service Corp
KIDS18.280.26
+1.44%
OrthoPediatrics Corp
FEAM3.660.02
+0.55%
5E Advanced Materials Inc.
IVDA1.20-0.12
-9.09%
Iveda Solutions Inc

CLVLF and

Correlation & Price change

A.I.dvisor tells us that CLVLF and IONS have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CLVLF and IONS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLVLF
1D Price
Change %
CLVLF100%
N/A
IONS - CLVLF
28%
Poorly correlated
+1.78%
MCRB - CLVLF
24%
Poorly correlated
+0.53%
PXXLF - CLVLF
23%
Poorly correlated
N/A
NICXF - CLVLF
22%
Poorly correlated
N/A
QNRX - CLVLF
22%
Poorly correlated
-1.73%
More

QNRX and

Correlation & Price change

A.I.dvisor tells us that QNRX and PRQR have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that QNRX and PRQR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QNRX
1D Price
Change %
QNRX100%
-1.73%
PRQR - QNRX
32%
Poorly correlated
+1.93%
WVE - QNRX
32%
Poorly correlated
+2.10%
ETHZ - QNRX
29%
Poorly correlated
+7.73%
ALGS - QNRX
28%
Poorly correlated
+4.59%
BDRX - QNRX
27%
Poorly correlated
-3.93%
More